Author

Norbert Reiling

Primary ORCID profile (0000-0001-6673-4291 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Norbert ReilingiD2 papers · German Center for Infection Research

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:structural biology· 1

Frequent Co-Authors

Christian C. Gruber· 1 shared Christoph Grininger· 1 shared Gareth Prosser· 1 shared Jörg Lichtenegger· 1 shared Laura Gödl· 1 shared Lena Parigger· 1 shared Lina Riegler-BerketiD· 1 shared Monika ObereriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Christian C. Gruber

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

M. tuberculosis meets European Lead Factory - identification and structural characterization of novel Rv0183 inhibitors using X-ray crystallography

Lina Riegler-Berket, Laura Gödl, Nakia Polidori, Philipp Aschauer, Christoph Grininger, Gareth Prosser, Jörg Lichtenegger, Theo Sagmeister, Lena Parigger, Christian C. Gruber, Norbert Reiling, Monika Oberer

This study identifies and characterizes novel Rv0183 inhibitors using high-throughput screening and X-ray crystallography, demonstrating species-selective inhibition against Mycobacterium tuberculosis.

bioRxiv · Jun 12, 2025Biochemistry